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Cancer treatment by cold atmospheric plasma (CAP) offers the possibility to selectively eliminate cancer cells while 
leaving surrounding, normal cells, unaffected. The mechanisms underlying the CAP selectivity towards cancer cells 
are yet not fully understood, but based on experimental findings, it has been proposed that two apoptosis-inducing 
signaling pathways - which are inhibited by catalase - in the extracellular compartment are reactivated when catalase 
in the cell membrane of cancer cells is inactivated. Since CAP has the capacity to inactivate catalase, CAP may thus 
be used to induce cancer cell death by reactivation of these signaling pathways. A better insight of this specific 
apoptosis-inducing mechanism - especially the role of catalase inactivation - could be useful to increase our 
understanding of possible roles of CAP constituents in cancer treatment. In the present study, a mathematical model 
describing the reaction kinetics of the two apoptosis-inducing signaling pathways is developed and used to 
theoretically investigate their catalase-dependent reactivation. The results show that when only the reaction kinetics 
is considered, just one of the pathways may be responsible for apoptosis induction. This pathway requires a high 
catalase concentration (in the order of 𝑚𝑀) to be inhibited, which thus can be assumed to be the condition of cancer 
cells before CAP treatment, and it can only be reactivated by inactivation of about 99% of the catalase. This model 
is a first step into the efforts that should be taken to quantitatively understand the complex mechanisms of the role 
of CAP and catalase in the apoptosis-inducing signaling pathways, but will need to be further extended before it can 
capture the entire mechanism. Still, it gives some important insights regarding necessary conditions in order for the 
proposed mechanism to represent a feasible explanation of selective CAP treatment of cancer cells. 
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1. Introduction 
 
Recently, application of cold atmospheric plasma (CAP) on cancer tissue has emerged as a novel, 
promising cancer treatment, and up to now, CAP has shown significant effect in over 20 different 
types of cancer cell lines (in vitro) including brain cancer 1-2, skin cancer 3-5, breast cancer 6-7, 
colorectal cancer 8-9, lung cancer 10-11, cervical cancer 12-13 and leukemia 14-15. The first results from 
clinical application of CAP in cancer treatment are equally encouraging 16-18. A special feature - 
and great advantage compared to most conventional cancer treatments - is the possibility to 
selectively eliminate cancer cells while leaving normal cells unaffected 8, 10, 19-28, although this 
selectivity is not always observed and depends on the treatment conditions 29. 
 
It is generally accepted that the anti-cancer effect of CAP to a great extent is associated with 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated in CAP. Especially, 
a rise of intracellular ROS in cancer cells (but not in normal cells) upon CAP treatment has been 
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reported 22, 24, 30-32. The significance of this intracellular rise of ROS has been experimentally 
verified by the observation that CAP treatment fails to eliminate cancer cells when these are 
pretreated with intracellular ROS scavengers 2, 30-31. Furthermore, CAP has been shown to trigger 
apoptosis in cancer cells in vitro and in vivo 10, 33-42. In the light of these findings, it has been argued 
that the anti-cancer effect of CAP is related to apoptosis-induction mediated by ROS and RNS 30, 
39, 41, 43-46.  
 
So far, most of the published work on the mechanisms underlying the anti-cancer effect of CAP is 
based on the idea that CAP contains ROS and RNS in sufficient concentration to induce apoptosis 
in cancer cells. However, a major change of concept - that accounts for selectivity in a very 
sophisticated manner - has been developed by Bauer and Graves 37. In this concept, CAP-generated 
ROS and RNS are believed to merely be the trigger to (re)activate apoptosis-inducing signaling 
pathways in the extracellular compartment of cancer cells. When (re)activated, these pathways 
thus transfer the signal to eliminate cells by self-destruction through apoptosis. Due to a difference 
in the extracellular compartment of cancer cells compared to normal cells, CAP will not trigger an 
activation of such apoptosis-inducing signaling pathways in normal cells - hence, the selectivity 
of CAP treatment. Recently, the first experiments evaluating this hypothesis were performed, with 
promising results 47-48. 
 
In the present study, we investigated the specific and detailed concept proposed in ref. 37, which is 
based on signaling pathways - originating from cell-derived species - occurring in the extracellular 
compartment of cancer cells. By mathematical modeling of the reaction kinetics of the apoptosis-
inducing signaling pathways, which we believe is the core concept of the full mechanism, we 
analyzed and evaluated this hypothesis from a theoretical point of view and tried to reveal its range 
of applicability. The aim of this study is to contribute to the understanding of a potential underlying 
mechanism of the selective anti-cancer effect of CAP. As our model only contains a part of the 
full mechanism (the latter is more complicated, and also contains other CAP-associated 
mechanisms, such as the role of aquaporins and immune response), we cannot yet directly compare 
our results with the experiments of ref. 47, so this work is only a first step into investigating the 
proposed mechanism underlying the selective anticancer effect of CAP. We believe a stepwise 
model development approach, starting with a predictive model of the most essential components 
of the underlying mechanism, is an appropriate implementation as it allows to reject implausible 
scenarios along the way before increasing the complexity of the system. As a framework for the 
modeling, we first briefly discuss the apoptosis-inducing signaling pathways and how they are 
reactivated by CAP, and we present the motivation for this study as well as the explicit research 
questions. 
 
 
2. Reactivation of apoptosis-inducing signaling pathways by CAP 
 
 
Explicitly, the difference (of importance in this context) between cancer cells and normal cells, as 
briefly mentioned in the introduction, is to its simplest description based on two features that only 
cancer cells hold: 
 
• Generation of extracellular superoxide anions.  
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• Membrane-associated catalase. 
 
The extracellular superoxide anion generating enzyme NOX1 has been connected to cancer cell 
proliferation (i.e., the growth of cancer cells) 49-60 and the generation of superoxide anions by 
several cancer cell lines has been reported 61-62. Furthermore, there are studies showing that cancer 
progression requires the expression of membrane-associated catalase 63-67. How these two features 
can be used to achieve selective cancer treatment by application of CAP is explained in the 
following three subsections. 
 
 
2.1 Apoptosis-inducing signaling pathways originating from superoxide anions  
 
The extracellular NOX1-generated superoxide anions are also the precursor of two apoptosis-
inducing signaling pathways; the hypochlorous acid-pathway and the nitric oxide/peroxynitrite-
pathway 63-64, 68-70. Together these pathways form what will be referred to as a reaction network. 
Both pathways in the reaction network result in the generation of hydroxyl radicals - a species 
causing apoptosis-induction through lipid peroxidation in the cell membrane. In the hypochlorous 
acid pathway, hydrogen peroxide	is formed from superoxide anions in a reaction catalyzed by 
superoxide dismutase (SOD). Subsequently, hydrogen peroxide	is used to synthesize 
hypochlorous acid in a reaction catalyzed by peroxidase (POD). Thereafter, hypochlorous acid 
reacts with superoxide anions	to form hydroxyl radicals. In the nitric oxide/peroxynitrite pathway, 
superoxide anions	first reacts with nitric oxide to form peroxynitrite. Subsequently, protonation of 
peroxynitrite forms peroxynitrous acid, which decomposes into nitrogen dioxide and hydroxyl 
radicals. For a schematic illustration of the two pathways in the reaction network, see Fig. 1.  
 
 
 
Fig. 1: Reaction network. Schematic illustration of the reaction network of apoptosis-inducing signaling pathways: 
the hypochlorous acid- and the nitric oxide/peroxynitrite pathway. Both pathways originate from superoxide anions 
and result in the formation of hydroxyl radicals which is responsible for apoptosis-induction. 
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2.2 The protective role of catalase 
 
According to the concept in ref. 37, the function of membrane-associated catalase in the 
extracellular compartment of cancer cells is to maintain the concentration of generated hydroxyl 
radicals below the threshold of apoptosis-induction. Extracellular membrane-associated catalase 
decomposes hydrogen peroxide into water and oxygen and thus removes the substrate for 
hypochlorous acid production 65, 67. In addition, catalase can reduce the formation of peroxynitrite 
(through oxidation of nitric oxide 71) as well as decompose peroxynitrite into nitrite  and oxygen  
34, 67, 72. Since the formation of peroxynitrite through reaction of nitric oxide and superoxide anions 
is very fast (much faster than the interaction between nitric oxide and catalase), it is reasonable to 
assume that the latter constitutes the major contribution to the peroxynitrite lowering effect of 
catalase. This conclusion was also drawn in e.g. ref. 34. For a schematic illustration of the effect of 
catalase on the reaction network presented in Fig. 1, see Fig. 2. Since normal cells lack the 
generation of superoxide anions into the extracellular compartment, catalase is only expressed in 
the intracellular compartment (where ROS are generated from e.g. the mitochondria).  
 
 
 
Fig 2: Reaction network with catalase. Catalase prevents the formation of hydroxyl radicals in both apoptosis-
inducing signaling pathways. In the hypochlorous acid pathway, this occurs through decomposition of hydrogen 
peroxide into water and oxygen, and in the nitric oxide/peroxynitrite pathway it proceeds through decomposition of 
peroxynitrite into nitrite and oxygen. 
 
 
2.3 Effect of CAP on cancer cells 
 
According to ref. 37, CAP causes (among others) selective cancer treatment due to its effect on 
catalase; it has been shown that singlet oxygen - which is one of the ROS known to be generated 
in CAP - has a strong potential to inactivate antioxidant enzymes, like catalase, through reaction 
with the histidine residues at the active centers 42. Thus, CAP may be used as a source of external 
singlet oxygen to inactivate the protective membrane-associated catalase in cancer cells. Applying 
CAP on tissue containing cancer cells will hence cause selective elimination of cancer cells 
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through reactivation of hydroxyl radicals generation from the hypochlorous acid- and the nitric 
oxide/peroxynitrite pathway in the extracellular compartment of these cells. A simplified cartoon 
picture of the events, forming the part that we believe is the core of the proposed mechanism of 
selective CAP treatment of cancer cells, can be seen in Fig. 3. 
 
 
 
Fig. 3: Plasma cancer treatment. Proposed set of events underlying the mechanism of selective cancer treatment 
with CAP. The cartoon picture represents a cancer cell and its extracellular compartment before, during and after CAP 
treatment. 
 
It should be noted that an important aspect of the full mechanism underlying the selectivity of 
cancer treatment by CAP as presented in ref. 37, is the hypothesis that the non-decomposed 
hydrogen peroxide and peroxynitrite in the vicinity of inactivated catalase, may generate a burst 
of secondary singlet oxygen, which is propagated to adjacent cancer cells. In this catalase-
dependent self-perpetuation of singlet oxygen, the effect of CAP is predicted to go beyond the 
surface of the cancer tumor, but the final effect on the bulk cancer cells is the same: inactivation 
of membrane-associated catalase and subsequent apoptosis-induction by the hypochlorous acid- 
and the nitric oxide/peroxynitrite pathway. 
 
 
2.4 Motivation and research questions 
 
Since a too high dose of CAP has been shown to cause cell death through necrosis rather than 
apoptosis - a process that is equally efficient in cancer cells as in normal cells 73 - an important 
issue for the future use of CAP in cancer treatment is how to adjust the ROS and RNS concentration 
(and composition) of CAP such that it allows to selectively eliminate cancer cells through 
apoptosis induction. In the context of the concept proposed in ref. 37 - which is the focus of the 
current study – this translates to determining in which regime CAP inactivates enough catalase to 
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reactivate hydroxyl radical generation in the extracellular compartment of cancer cells, but is well 
below the threshold for eliminating normal cells. The first step to accomplish this is of course to 
investigate how much catalase has to be inactivated in order to reactivate hydroxyl radical 
generation from the reaction network of the hypochlorous acid- and the nitric oxide/peroxynitrite 
pathway. This is the main motivation of our study. 
 
So far, the effect of catalase on the hypochlorous acid- and the nitric oxide/peroxynitrite pathway 
has only been investigated experimentally. In other similar systems, mathematical modeling has 
proven to be a useful approach to increase the knowledge of the mechanisms of cell antioxidant 
defense and cell signaling, see e.g. refs. 74-86. An advantage of a mathematical model is that it 
allows to probe the system’s behavior in ways that would not be possible in the lab. In the present 
study, a mathematical model of the kinetics of the proposed reaction network (catalase included) 
is developed and used to theoretically investigate the reactivation of the generation of hydroxyl 
radicals through inactivation of catalase. Numerical calculations are performed for various 
concentrations of catalase, to analyze the relationship between the catalase concentration and the 
generation of hydroxyl radicals. In particular, it is investigated to what extent catalase has to be 
inactivated in order for the hydroxyl radicals generation to be considered reactivated. The 
relationship between catalase inactivation and hydroxyl radicals generation in the reaction network 
of the hypochlorous acid- and the nitric oxide/peroxynitrite pathway is the specific research 
question that we seek to answer in this study. 
 
 
 
3. The mathematical model 
 
In this section, we present the construction and implementation of the mathematical model, 
describing the catalase-dependent kinetics of the reaction network in the extracellular compartment 
of cancer cells, and we point out the assumptions and simplifications underlying the model. 
 
 
3.1 Construction of the mathematical model 
 
Since this is the first attempt to construct a mathematical model of the reaction network of the 
hypochlorous acid- and nitric oxide/peroxynitrite pathways and its interaction with catalase, as our 
first simplification we choose to restrict the model to include the closed system of the reaction 
network (catalase-interaction included) itself only. Thus, any other possible interfering pathway 
or interaction with the surrounding is neglected. We admit that this model will not capture the full 
complexity of the kinetics of the reaction network in its in vitro or in vivo context, but we believe 
that it will provide fundamental insights about the kinetics of the reaction network itself and 
necessary conditions for catalase-dependent reactivation of hydroxyl radical generation. These 
insights can by extension be used as guidelines for further development of the model. 
 
As a second simplification, we assume that the extracellular compartment of a cancer cell can be 
thought of as a well-mixed reaction vessel. All involved species are thus homogenously 
distributed, i.e., 𝛻%𝑐' = 0, where 𝑐' is the concentration of species 𝑖, for all (𝑥,  𝑦,  𝑧). The motivation 
for only considering the reaction kinetics is as follows: When the spatial dynamics is included in 
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a mathematical model of a reaction network, the rates of reactions of the different species in the 
network are competing with their diffusional loss. Since the important species in the reaction 
network all are located close to the cell membrane in the extracellular compartment, we can assume 
that the local concentration of especially enzymes is high and reactions should forestall diffusion. 
Thus, diffusion becomes less important since the species most probably will react before diffusing 
from the site of production. This assumption is justified by a number of studies for the two key 
species nitric oxide and superoxide anions 76-77, 87-88. In these studies, the concentration of nitric oxide, 
superoxide anions and related species in the extracellular compartment of activated macrophages 
was investigated by mathematical modeling. Like cancer cells, macrophage cells generate both 
nitric oxide and superoxide anions into the extracellular compartment. In ref. 77 it was estimated 
that superoxide anions are depleted within 1	𝜇𝑚 above the cell surface and in ref. 76 it was found 
that both superoxide anions and peroxynitrite only exist in a very thin layer above the cell surface. 
In all these studies, nitric oxide reached the same steady-state concentration in the vicinity of the 
cells (despite different conditions such as cell density). Thus, in summary we are modelling the 
kinetics of the reaction network in a thin layer above the surface of one cancer cell as it would 
occur in a well-mixed reaction vessel. 
 
Explicitly, the mathematical model is used to analyze the behavior of the dependent variable 𝑦, 
defined as  
 𝑦(𝑥) = [•𝑂𝐻]::; . 
 
Here, 𝑥 denotes the set of independent variables that are varied in a particular system, which in our 
case is [𝐶𝐴𝑇]?,	i.e., 𝑥 = [𝐶𝐴𝑇]? and [𝐶𝐴𝑇]? denotes the initial concentration of catalase, while [•𝑂𝐻]::;  is the steady-state concentration of hydroxyl radicals (which is the dependent variable). In 
the numerical calculations,	𝑥 is given in per cent of [𝐶𝐴𝑇]?,@AB, where [𝐶𝐴𝑇]?,@AB denotes the 
reference value of the catalase concentration, i.e., corresponding to the concentration of catalase 
in the extracellular compartment of a cancer cell before CAP treatment. Thus, we are focusing on 
how many per cent of the original catalase concentration has to be inactivated in order to reactivate 
hydroxyl radical generation. 
 
We assume that the cellular generation rates of nitric oxide and superoxide anions  exactly balance 
the rates of consumption before 𝑡 = 0, i.e., the concentrations of nitric oxide and superoxide anions 
are constant (steady-state) before the disturbance of the kinetics by a change in the catalase 
concentration (due to the interaction between CAP and catalase). This disturbance is assumed to 
occur instantly at 𝑡 = 0 and the effect in the kinetics is monitored thereafter. Thus, regarding the 
extracellular compartment as a reaction vessel in an experiment, the time 𝑡 = 0 corresponds to the 
moment when the reaction vessel is prepared and the reading starts.  
 
Ideally, the model should be compared and - if necessary - calibrated to experimental results, but 
to the best of our knowledge, there are no experimental studies for the catalase-dependency of the 
concentration of generated hydroxyl radicals in the extracellular compartment of cancer cells. 
Neither are there studies where an explicit correlation between the extracellular concentration of 
hydroxyl radicals and cancer cell apoptosis is reported - information that ultimately would be 
required as a reference value of when the hydroxyl radicals production can be considered 
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reactivated. For externally added hydroxyl radicals, the critical concentration to cause apoptosis-
induction for lung cancer H460 cells, is around 0.3 × 10FG	𝑐𝑚HI 89-90. This corresponds to [•𝑂𝐻] =5 × 10HG	𝑀, which could be a value to refer back to when we evaluate our results.  
 
It should be pointed out that in this study we do not consider how catalase is inactivated, i.e. if it 
is inactivated by primary singlet oxygen contained in CAP, secondary singlet oxygen  generated 
by the cells themselves or any other species (e.g. superoxide anions or nitric oxide). Even though 
the generation of secondary singlet oxygen is a very important part of the full mechanism 
underlying selectivity of CAP cancer treatment, as proposed in ref. 37, taking the propagation of 
secondary singlet oxygen into account is beyond the scope of this study. Here, we are only 
concerned with the two apoptosis-inducing signaling pathways themselves and the impact of 
catalase-interference on their ability to generate hydroxyl radicals. 
 
 
3.2 Reaction network 
 
The reaction network, representing both apoptosis-inducing signaling pathways in the extracellular 
compartment of a cancer cell and their interaction with catalase, consists of the following reactions: 
 (1)			2𝑂%•H + 2𝐻M 𝑘F→𝑆𝑂𝐷𝐻%𝑂% + 𝑂%, (2)			•𝑁𝑂 + 𝑂%•H 𝑘%⇌𝑘H%𝑂𝑁𝑂𝑂H, 
(3)   2𝐻%𝑂% 𝑘I→𝐶𝐴𝑇𝑂% + 2𝐻%𝑂, (4)		2𝑂𝑁𝑂𝑂H 𝑘U→𝐶𝐴𝑇𝑂% + 2𝑁𝑂%H, (5)			𝐻%𝑂% + 𝐶𝑙H + 𝐻M 𝑘W→𝑃𝑂𝐷𝐻𝑂𝐶𝑙 + 𝐻%𝑂, (6)			𝐻𝑂𝐶𝑙 + 𝑂%•H 𝑘G⇌𝑘HG •𝑂𝐻 + 𝐶𝑙H + 𝑂%, (7)			𝑂𝑁𝑂𝑂H + 𝐻M 𝑘[⇌𝑘H[𝑂𝑁𝑂𝑂𝐻, (8)			𝑂𝑁𝑂𝑂𝐻 𝑘]⇌𝑘H] •𝑁𝑂% +  •𝑂𝐻, 
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where 𝑘'	is the rate constant of the forward reaction for reaction (𝑖) and 𝑘H' is the rate constant for 
the backward reaction. Enzyme-catalyzed reactions are assumed to only proceed in the forward 
direction, in accordance with the assumptions for which experimental parameter values exist 91-92.  
 
Reaction (1), (3), (5)	and (6) form the hypochlorous acid pathway, whereas reaction (2), (4), (7) 
and (8) form the nitric oxide/peroxynitrite pathway.  
 
 
3.3 Rate equations 
 
The kinetics of a reaction network is given by the set of rate equations describing the rate of 
production and consumption of each species in the network. Here, the explicit equations are 
summarized, as well as the assumptions made. A more detailed description of the rate equations 
and the references from where they have been taken, can be found in the Appendix (section A1). 
Note that the reactions (1)-(8) are not elementary reactions, but rather consist of many different 
elementary reactions that we do not know about. The information available is the rate constants 
and reaction order for each species in the overall reaction, as they appear in experiments 72, 91-102. 
Hence, not all rate equations follow the law of mass action, but have other, experimentally 
observed, forms. More information is given in the Appendix, section A1. 
 
We assume that [𝐻M] is kept constant over time (due to a constant generation by proton pumps), 
i.e.,  
 𝑑[𝐻M]𝑑𝑡 = 0. 
 
Furthermore, we assume that [𝐶𝑙H] is kept constant over time (due to a high physiological 
concentration compared to the other species), i.e.,  
 𝑑[𝐶𝑙H]𝑑𝑡 = 0. 
 
Finally, we assume that the catalysts, [𝑆𝑂𝐷],	 [𝐶𝐴𝑇] and [𝑃𝑂𝐷], are kept constant over time, i.e.,  
 𝑑[𝐸]𝑑𝑡 = 0, 
 
where 𝐸 denotes 𝑆𝑂𝐷, 	𝐶𝐴𝑇 or 𝑃𝑂𝐷. 
 
The set of coupled rate equations, solving the time-dependence of the concentration of the different 
species, is then given by (see Appendix A1 for more details): 
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𝑑[𝑂%•H]𝑑𝑡 = −[𝑂%•H](𝑘F[𝑆𝑂𝐷] + 𝑘%[•𝑁𝑂] + 𝑘G[𝐻𝑂𝐶𝑙]) + 𝑘H%[𝑂𝑁𝑂𝑂H] + 𝑘HG[•𝑂𝐻][𝐶𝑙H][𝑂%], 𝑑[𝐻M]𝑑𝑡 = 0, 𝑑[𝐻%𝑂%]𝑑𝑡 = 12𝑘F[𝑂%•H][𝑆𝑂𝐷] − [𝐻%𝑂%] a2𝑘I[𝐶𝐴𝑇]? 1𝐾I + [𝐻%𝑂%] + 𝑘W[𝑃𝑂𝐷]? 1𝐾W + [𝐻%𝑂%]c, 𝑑[•𝑁𝑂]𝑑𝑡 = −𝑘%[•𝑁𝑂][𝑂%•H] + 𝑘H%[𝑂𝑁𝑂𝑂H], 𝑑[𝑂𝑁𝑂𝑂H]𝑑𝑡 = 𝑘%[•𝑁𝑂][𝑂%•H] − [𝑂𝑁𝑂𝑂H](𝑘H% + 𝑘U[𝐶𝐴𝑇] + 𝑘[[𝐻M]) + 𝑘H[[𝑂𝑁𝑂𝑂𝐻], 𝑑[𝐶𝑙H]𝑑𝑡 = 0, 𝑑[𝐻𝑂𝐶𝑙]𝑑𝑡 = 𝑘W[𝑃𝑂𝐷]? [𝐻%𝑂%]𝐾W + [𝐻%𝑂%] − 𝑘G[𝐻𝑂𝐶𝑙][𝑂%•H] + 𝑘HG[•𝑂𝐻][𝐶𝑙H][𝑂%], 𝑑[•𝑂𝐻]𝑑𝑡 = 𝑘G[𝐻𝑂𝐶𝑙][𝑂%•H] − [•𝑂𝐻](𝑘HG[𝐶𝑙H][𝑂%] + 𝑘H][•𝑁𝑂%]) + 𝑘][𝑂𝑁𝑂𝑂𝐻], 𝑑[𝑂𝑁𝑂𝑂𝐻]𝑑𝑡 = 𝑘[[𝑂𝑁𝑂𝑂H][𝐻M] − [𝑂𝑁𝑂𝑂𝐻](𝑘H[ + 𝑘]) + 𝑘H][•𝑁𝑂%][•𝑂𝐻], 𝑑[•𝑁𝑂%]𝑑𝑡 = 𝑘][𝑂𝑁𝑂𝑂𝐻] − 𝑘H][•𝑁𝑂%][•𝑂𝐻], 𝑑[𝑆𝑂𝐷]𝑑𝑡 = 0, 𝑑[𝑃𝑂𝐷]𝑑𝑡 = 0, 𝑑[𝐶𝐴𝑇]𝑑𝑡 = 0. 
 
Here, 𝐾' is the Michaelis-Menten constant for reaction (𝑖). 
 
Note that even though the set of rate equations are solved with respect to 𝑡, we are in this study not 
interested in the explicit time-dependence of each species but only the steady-state concentration 
of hydroxyl radicals as a function of the catalase concentration (see section 3.1). 
 
 
4. Numerical details 
 
In this section, we provide details of the numerical calculations, especially the parameter values 
used in the calculations. 
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4.1 Parameter values 
 
The rate constants used in this study were collected from the literature, and in the case several 
different values were reported, the value that optimizes the production of hydroxyl radicals is used 
to create the upper limit for the hydroxyl radical production (see the Appendix, section A1, for 
more details).  
 
The used rate constants for the non-enzyme catalyzed reactions, i.e. reaction (2), (6), (7) and (8), 
are summarized in Tab. 1. If not explicitly stated otherwise, the rate constants are for 𝑇 = 37℃ and 𝑝𝐻~7. 
 
Tab. 1: Parameter values of the rate constants of the non-enzyme catalyzed reactions. 
Rate constant Value Reference Remark 𝑘% 1.7 × 10F?	𝑀HF𝑠HF 93 No information about 𝑝𝐻. 𝑘H% 17 × 10HI	𝑠HF 100-101 𝑇 = 20 − 25℃  𝑘G 7.5 × 10G	𝑀HF𝑠HF 94 𝑇~20℃, 𝑝𝐻 = 5.5 𝑘HG 0  Assigned 𝑘[ 10F?	𝑀HF𝑠HF 96  𝑘H[ 𝑘[𝐾h, 𝑝𝐾h = 6.8 102   𝑘] 0.6	𝑠HF 98 𝑇 = 25℃, no 
information about 𝑝𝐻. 𝑘H] 3.5 × 10i	𝑀HF𝑠HF 99 𝑝𝐻 = 9.5, no 
information about 𝑇. 
 
The used kinetic parameter values of the enzyme catalyzed reactions, i.e., reaction (1), (3), (4) and (5), are summarized in Tab. 2. If not explicitly stated otherwise, the parameter values are for homo 
sapiens and for 𝑇 = 37℃ and 𝑝𝐻~7. 
 
Tab. 2: Parameter values of the rate constants and Michaelis-Menten constants of the enzyme catalyzed reactions. 
Enzyme Kinetic parameter Reference Remark 
SOD 𝑘F = 2.35 × 10i	𝑀HF𝑠HF 95, 97 Bovine, 𝑇~25℃ 
CATklml 𝐾I = 80.0 × 10HI	𝑀,  𝑘I = 0.587 × 10G	𝑠HF 91 [𝐻%𝑂%] ≤ 200	𝑛𝑀 
CATmpmmq 𝑘U = 1.7 × 10G	𝑀HF𝑠HF 72 Bovine, 𝑇 = 25℃  
POD 𝐾W = 30 × 10HG	𝑀,  𝑘W = 320	𝑠HF 92 𝑡 ≤ 100	𝑚𝑠 
 
 
Since we wish to investigate the kinetics of the species truly originating from superoxide anions, 
i.e., without an external source of hydrogen peroxide, peroxynitrite, peroxynitrous acid, 
hypochlorous acid, hydroxyl radicals or nitrogen dioxide, all initial concentrations, except of [𝑂%•H]?, [•𝑁𝑂]?, [𝐻M]?, [𝐶𝑙H]?, [𝐶𝐴𝑇]?, [𝑆𝑂𝐷]? and [𝑃𝑂𝐷]? were set to zero. The nonzero initial 
concentrations were taken from appropriate sources. We assumed 𝑝𝐻 = 7, i.e., [𝐻M]? = 10H[	𝑀. 
The used initial concentrations of the ROS and RNS are summarized in Tab. 3. The initial 
concentration of nitric oxide (ref. 103) is an experimental value measured at the surface of a 
stimulated endothelial cell (𝑇 = 37℃). This was the literature value found for conditions that best 
resemble ours. This value is also supported by other studies: for macrophages cells, the (steady-
state) concentration of nitric oxide in the vicinity of the cells was ∼ 1𝜇𝑀 77, 87-88. The initial 
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concentration of superoxide anions (ref. 76) is the steady state concentration of superoxide anions 
in the extracellular compartment of macrophage cells, which was found to be in the order of 𝑛𝑀. 
 
For the initial concentration of the enzymes in the extracellular compartment of cancer cells, no 
experimental values could be found. How this issue was dealt with is described in the results 
section. 
 
 
Tab. 3: Initial concentrations of the ROS and RNS. 
Species Initial concentration (M) Reference Remark 𝑂%•H 10Hi 76  𝐻M 10H[  Assigned 𝐻%𝑂% 0  Assigned •𝑁𝑂 10HG 103 In stimulated endothelial 
cells 𝑂𝑁𝑂𝑂H 0  Assigned 𝐶𝑙H 0.140 104  𝐻𝑂𝐶𝑙 0  Assigned •𝑂𝐻 0  Assigned 𝑂𝑁𝑂𝑂𝐻 0  Assigned •𝑁𝑂% 0  Assigned 
 
It should be noted that the parameter values used in this study were taken from experiments 
performed under conditions that most likely deviate in one or many aspects from the true in vitro 
or in vivo conditions in the extracellular compartment of a cancer cell. Having this in mind, we 
believe these parameter values are still a good starting point for the purpose of these numerical 
calculations. 
 
4.2 Software and details about the calculations 
 
The numerical calculations were performed in MATLAB. Due to significant differences in time 
scales, we used the solver ode23s to solve the set of rate equations. 
 
In order to determine the most suitable time resolution and time scale for the calculations, we 
performed a number of test runs (fixed input parameter values), and we found on the time scale of 1	𝑚𝑠 no significant difference in the calculation outcome for a single run with [𝐶𝐴𝑇]? = [𝐶𝐴𝑇]?,@AB 
between using 𝑑𝑡 = 1	𝜇𝑠 (𝑑𝑡 denoting the time resolution) as compared to 𝑑𝑡 = 1	𝑛𝑠. The same 
was true when [𝐶𝐴𝑇]? = 0	𝑀. Hence we determined that a time resolution of 1	𝜇𝑠 yielded a result 
with desired accuracy. Since [•𝑂𝐻] reaches a steady-state on the 10	𝑠- time scale when [𝐶𝐴𝑇]? =0	𝑀 (and 100	𝑚𝑠 when [𝐶𝐴𝑇]? = [𝐶𝐴𝑇]?,@AB - the value of [𝐶𝐴𝑇]?,@AB will be discussed in section 
5.1), we used 𝑡B = 10	𝑠 (𝑡B denoting the final time) in the calculations. Hence, we performed the 
numerical calculations for 𝑑𝑡 = 1	𝜇𝑠 and 𝑡B = 10	𝑠. 
 
We varied the concentration of catalase according to 0 ≤ [𝐶𝐴𝑇]? ≤ [𝐶𝐴𝑇]?,@AB (see section 3.1), 
using interval steps, 𝛥[𝐶𝐴𝑇]? = 0.01[𝐶𝐴𝑇]?,@AB. 
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5. Results and discussion 
 
5.1 Revealing the dominant signaling pathway for generation of hydroxyl radicals  
 
Since we could not find experimental values for the concentration of the different enzymes in the 
extracellular compartment of cancer cells, we first performed a model analysis to assign feasible 
values for these parameters. 
 
Information about the faith of superoxide anions - in particular which pathway contributes the most 
to the generation of hydroxyl radicals under the given conditions - can be extracted by considering 
the rates by which superoxide anions is consumed in the different pathways. The first reaction in 
each pathway is given by reaction (1) (the hypochlorous acid pathway) and (2) (the nitric 
oxide/peroxynitrite pathway). For short times, the rate, 𝑣F and 𝑣%, of superoxide anion consumption 
in each of these reactions is: 
 𝑣F = −𝑘F[𝑂%•H]?[𝑆𝑂𝐷]?, 𝑣% = −𝑘%[𝑂%•H]?[•𝑁𝑂]?. 
 
The ratio of the initial rates is hence  
 𝑣%𝑣F = 𝑘%[•𝑁𝑂]?𝑘F[𝑆𝑂𝐷]?. 
 
Inserting the values of 𝑘F, 𝑘% and [•𝑁𝑂]? (see Tab. 1, 2 and 3) yields 
 𝑣%𝑣F ∼ 10HW[𝑆𝑂𝐷]?. 
 
From this ratio of the initial consumption rates of superoxide anions in the two pathways, we can 
see that the value of [𝑆𝑂𝐷]? (which is unknown) defines which one of three different regimes of 
the combined reaction network of the hypochlorous acid- and the nitric oxide/peroxynitrite 
pathway we are considering. Indeed, since the rate equation for SOD-catalyzed dismutation of 
superoxide anions is not given by a Michael-Menten equation (see ref. 97), we are not constrained 
by the condition [𝑆𝑂𝐷]? ≪ [𝑂%•H], but we can explore the whole regime of SOD-concentrations. 
The SOD-defined pathway regimes, according to this model and initial conditions, are: 
 
1. The nitric oxide/peroxynitrite pathway regime occurs for [𝑆𝑂𝐷]? ≲ 10H[	𝑀,  ([𝑆𝑂𝐷]? = 10H[	𝑀 ⇒ 𝑣% ∼ 100𝑣F). 
 
2. The combined pathway regime occurs for 10H[	𝑀 ≲ [𝑆𝑂𝐷]? ≲ 10HI	𝑀. 
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3. The hypochlorous acid pathway regime occurs for [𝑆𝑂𝐷]? ≳ 10HI	𝑀, ([𝑆𝑂𝐷]? = 10HI	𝑀 ⇒ 𝑣F ∼ 100𝑣%). 
 
If we assume that the SOD-molecules are solid spheres (in such a case their radius is in the order 
of 𝑟 = 16	𝐴z  - see Appendix, section A2), the volume that one SOD-molecule is occupying is given 
by a cube with the side length 2𝑟. The physical limit for the concentration of SOD is thus (𝑁{= 
Avogadro’s constant): 
 [𝑆𝑂𝐷]|h; = 1𝑁{ 18𝑟I ∼ 50 × 10HI	𝑀. 
 
Thus, in order for the hypochlorous acid pathway to be dominant under the given conditions, the 
concentration of SOD has to be of the same order of magnitude as the physically maximal 
concentration of SOD. Moreover, since the generation of hydroxyl radicals in the hypochlorous 
acid pathway occurs through the reaction (i.e., reaction (6)  in the reaction network in section 3.2)  
 
			𝐻𝑂𝐶𝑙 + 𝑂%•H 𝑘G⇌𝑘HG •𝑂𝐻 + 𝐶𝑙H + 𝑂%, 
there will not be a significant generation of hydroxyl radicals for this pathway, even in the regime 
where it is dominant. This can be seen by making an analysis of the rate of formation of hydroxyl 
radicals, which is given by 
 𝑣′G = −𝑣G = 𝑘G[𝐻𝑂𝐶𝑙]~[𝑂%•H]~, 
 
where 𝑣G is the rate of superoxide anions consumption in reaction (6). The subscript 𝑡 is used to 
emphasize that the concentrations no longer are at their initial values. Since superoxide anions is 
a precursor of hypochlorous acid, there is a trade-off between a high concentration of hypochlorous 
acid and a high concentration of superoxide anions. If [𝐶𝐴𝑇]? = 0, then reaction (3) does not occur. 
If furthermore the nitric oxide/peroxynitrite pathway is neglected, i.e., reaction (2) is removed, 
then all superoxide anions will form hydrogen peroxide. Thus, the yield of hypochlorous acid is 
maximal. Furthermore, 𝑘HG = 0 (see Tab. 1). In reaction (1) it can be seen that the stoichiometry 
is such that 2 moles of superoxide anions yield 1 mole of hydrogen peroxide. Reaction (5) reveals 
that 1 mole of hydrogen peroxide yields 1 mole of hypochlorous acid. At time 𝑡, the concentration 
of superoxide anions ([𝑂%•H]~) will be the difference between the initial concentration of superoxide 
anions ([𝑂%•H]?) and the fraction of the initial concentration of superoxide anions (𝑓~) that has been 
used in the formation of hypochlorous acid at time 𝑡 ([𝐻𝑂𝐶𝑙]~). Thus, [𝑂%•H]~ = [𝑂%•H]? − 𝑓~. Since 
for each mole of formed hypochlorous acid, 2 moles of superoxide anions were required, 𝑓~ =2[𝐻𝑂𝐶𝑙]~, we get [𝑂%•H]~ = ([𝑂%•H]? − 2[𝐻𝑂𝐶𝑙]~). The rate 𝑣′G is hence a function of [𝐻𝑂𝐶𝑙]~: 𝑣′G([𝐻𝑂𝐶𝑙]~) = −𝑘G[𝐻𝑂𝐶𝑙]~([𝑂%•H]? − 2[𝐻𝑂𝐶𝑙]~). 
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If we for now denote [𝐻𝑂𝐶𝑙]~ = 𝑥 and [𝑂%•H]? = 𝑐? in the derivation, then the rate of formation of 
hydroxyl radicals is given by: 𝑣′G(𝑥) = 𝑘G𝑥(𝑐? − 2𝑥) = 𝑘G𝑥𝑐? − 2𝑘G𝑥%. 
Furthermore, 𝑑𝑣′G𝑑𝑡 = 𝑘G𝑐? − 4𝑘G𝑥, 
and 𝑑%𝑣′G𝑑𝑡% = −4𝑘G < 0. 
The maximum (since l~l < 0), of the rate of formation of hydroxyl radicals is thus given by 𝑑𝑣′G𝑑𝑡 = 0 ⇒ 𝑘G𝑐? − 4𝑘G𝑥|h; = 0 ⇔ 𝑥|h; = 𝑐?4 . 
 
Hence, the function 𝑣′G has a maximum, 𝑣′G,|h;, at 
 [𝐻𝑂𝐶𝑙]~,|h; = [𝑂%•H]?4 . 
 
The ratio between the rate of superoxide anions consumption in reaction (1) and reaction (6) at 
time (𝑡) is  ([𝑆𝑂𝐷]~ = [𝑆𝑂𝐷]?) 𝑣F𝑣G = 𝑘F[𝑆𝑂𝐷]?𝑘G[𝐻𝑂𝐶𝑙]~. 
 
Inserting [𝐻𝑂𝐶𝑙]~,|h; and the values of 𝑘F and 𝑘G (see Tab. 1 and 2) yields 
 𝑣F𝑣G,|h; = 4𝑘F[𝑆𝑂𝐷]?𝑘G[𝑂%•H]? ~10I[𝑆𝑂𝐷]?[𝑂%•H]? . 
 
In order for these two reactions to occur at approximately the same rate (given that [𝑂%•H]? =10Hi	𝑀, see Tab. 3), [𝑆𝑂𝐷]?~10HF%	𝑀. In such a case, in order for reaction (1) and (2) to occur at 
approximately the same rate, [•𝑁𝑂]? has to be several orders of magnitude smaller than the value 
reported in Tab. 3. In fact, [•𝑁𝑂]?~10HFI	𝑀.  
 
For [𝑆𝑂𝐷]? ∼ 10HI	𝑀 (the hypochlorous acid pathway regime), 𝑣F~10i𝑣G,|h;, i.e., the generation 
of hydroxyl radicals from reaction (6) is negligible. Hence, the kinetics of the reaction network 
suggests that the hypochlorous acid pathway regime is insignificant regarding the possibility to 
reactivate hydroxyl radicals generation.  
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For the second regime, where both pathways come into play, the same reasoning applies; there 
will not be a significant amount of hydroxyl radicals generated from the hypochlorous acid 
pathway and any superoxide anions going into the hypochlorous acid pathway will decrease the 
total hydroxyl radicals production of the reaction network. Thus, the interesting regime to 
investigate is the first regime where the nitric oxide/peroxynitrite pathway operates alone. 
 
Regarding the nitric oxide/peroxynitrite pathway alone (i.e., [𝑆𝑂𝐷]? ≲ 10H[	𝑀) the only enzyme-
catalyzed reaction (with catalase) is not given as a Michaelis-Menten mechanism (see ref. 91), so 
in this case it should be feasible to use the physically maximal concentration of catalase as [𝐶𝐴𝑇]?,@AB (see section 3.1) to explore the whole regime of possible catalase concentrations. We 
thus used the concentration of catalase when the whole extracellular compartment is maximally 
filled with catalase as our default reference value.  This concentration was found in the same 
manner as in the case of SOD. The radius is now 𝑟 = 25	𝐴z  (see Appendix, section A2) which yields [𝐶𝐴𝑇]?,|h; ∼ 10H%	𝑀.  
 
 
5.2 The catalase-dependence of the generation of hydroxyl radicals in the nitric 
oxide/peroxynitrite pathway 
 
Since it has been shown in the previous section that virtually no hydroxyl radicals is generated 
from the hypochlorous acid pathway in this model (even when the condition [𝑆𝑂𝐷] ≳ 10HI	𝑀 is 
fulfilled), we have chosen to exclude the hypochlorous acid pathway from the numerical 
calculations and instead we focused solely on the nitric oxide/peroxynitrite pathway.  
 
Fig. 4 illustrates the steady state hydroxyl radical concentration, 𝑦(𝑥), as a function of the catalase 
concentration, 𝑥, more specifically as % of  [𝐶𝐴𝑇]?,@AB.  
 
 
 
17 
 
 
 
Fig 4: Hydroxyl radical concentration as a function of catalase concentration. The catalase concentration is given 
as % of a reference value, which in this calculation was 10H%	𝑀 (see section 5.1 above).  
 
Assuming that [𝐶𝐴𝑇]? = 0 corresponds to a fully reactivated pathway, we can see that a catalase 
concentration of 10% of [𝐶𝐴𝑇]?,@AB, reduces [•𝑂𝐻] by three orders of magnitude (from [•𝑂𝐻]~10Hi.G	𝑀 = 2.5 × 10HF?	𝑀 to [•𝑂𝐻]~10HF%.[	𝑀 = 2.0 × 10HFI	𝑀). For catalase 
concentrations 0.1[𝐶𝐴𝑇]?,@AB ≤ ?̅? ≤ [𝐶𝐴𝑇]?,@AB , on the other hand, [•𝑂𝐻] only drops by about one 
order of magnitude. Therefore, it should be reasonable to assume that the catalase concentration 
in the extracellular compartment of cancer cells (before CAP treatment) is about 1	𝑚𝑀 or more. 
Indeed, this concentration seems to significantly reduce the hydroxyl radical concentration, and 
thus protects cancer cells from apoptosis. For a (nearly) fully reactivated pathway, most of the 
catalase needs to be inactivated.  
 
Based on the above conclusion, new calculations with [𝐶𝐴𝑇]?,@AB = 1	𝑚𝑀 were performed. The 
result can be seen in Fig. 5. This plot looks very similar to that shown in Fig. 4; again, ;̅ is larger 
for smaller ?̅?  and in the region of ?̅? ≤ 0.1[𝐶𝐴𝑇]?,@AB, the concentration of hydroxyl radicals drops 
by about two orders of magnitude (from [•𝑂𝐻]~10Hi.G	𝑀 = 2.5 × 10HF?	𝑀  to [•𝑂𝐻]~10HFF.[	𝑀 =2.0 × 10HF%	𝑀), whereas in the region 0.1[𝐶𝐴𝑇]?,@AB ≤ ?̅? ≤ [𝐶𝐴𝑇]?,@AB it only drops by about one 
order of magnitude. Still, for a (nearly) fully reactivated pathway, approximately 99% of the 
catalase has to be inactivated. In ref. 105 it is shown that in experiments with catalase in solution, 
the concentration has to be very high in order to inactivate the nitric oxide/peroxynitrite pathway. 
Hence, our model seems to reproduce this experimental result. 
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Additional calculations with [𝐶𝐴𝑇]?,@AB = 1	𝜇𝑀 were also performed. This result can be seen in 
Fig. 6. A catalase concentration of 1	𝜇𝑀 only lowers the generated hydroxyl radicals by less than 
one order of magnitude and is thus not enough to protect the cancer cell from the nitric 
oxide/peroxynitrite pathway.  
 
Comparing the concentration of generated hydroxyl radicals at [𝐶𝐴𝑇]? = 0	𝑀 (i.e., [•𝑂𝐻] =2.5 × 10HF?	𝑀) with the experimental result in ref. 89-90 (i.e., critical hydroxyl radical concentration 
for apoptosis-induction, [•𝑂𝐻] = 5 × 10HG	𝑀, as mentioned in section 3.1), we can see that when 
hydroxyl radicals is added externally, a concentration almost four orders of magnitude higher is 
required to induce apoptosis. However, since hydroxyl radicals is a highly reactive species, the 
effective [•𝑂𝐻] at locations where it can lead to lipid peroxidation (and thus, apoptosis), might be 
much lower when added externally. 
 
 
 
Fig 5: Hydroxyl radical concentration as a function of catalase concentration. The catalase concentration is given 
as % of a reference value, which in this calculation was 10HI	𝑀. 
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Fig 6: Hydroxyl radical concentration as a function of catalase concentration. The catalase concentration is given 
as % of a reference value, which in this calculation was 10HG	𝑀. 
 
 
5.3 Possible interpretation of the mechanisms underlying the catalase-dependence of the 
generation of hydroxyl radicals  
 
The results shown in Figs. 4-6 reveal that the relation between 𝑥 = [𝐶𝐴𝑇]? and 𝑦 = [•𝑂𝐻]:: does 
not follow a simple expression. Can the key mechanisms underlying this behavior be 
understood? In the following we make the ansatz that the overall behavior of the nitric 
oxide/peroxynitrite pathway can be understood as a step-wise sequence of reactions, separated in 
time. 
The nitric oxide/peroxynitrite pathway consists of reaction (2), (4), (7) and (8). The first 
reaction, reaction (2), occurs very fast and results in a [𝑂𝑁𝑂𝑂H] in the (sub)𝑛𝑀-regime 
([𝑂𝑁𝑂𝑂H]|h; = 10Hi	𝑀 since [𝑂%•H]? = 10Hi	𝑀). The faith of peroxynitrite is governed by the 
ratio of the rates of its different pathways of consumption (here, the pathway consisting of the 
reverse of reaction (2) can be neglected due to a vanishing rate in comparison to the other two, 
see Tab. 1): decomposition by catalase (reaction (4)) and protonation into peroxynitrous acid 
(reaction (7)). The ratio between the rates of these two pathways of consumption is 𝑟 = 𝑣U𝑣[ = 𝑘U[𝐶𝐴𝑇]?𝑘[[𝐻M] . 
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Inserting the values from Tabs. 1-3, it can be seen that when the two pathways occur at the same 
rate, i.e., 𝑟 = 1, [𝐶𝐴𝑇]? ∼ 6 × 10HU	𝑀. If 𝑟 < 1, the protonation of peroxynitrite into 
peroxynitrous acid outcompetes the decomposition by catalase. This highlights the fact that 
protonation of peroxynitrite is a very crucial step in reactivating hydroxyl radical generation and 
hence, that the protective effect of catalase is pH-dependent in a linear manner. It suggests that in 
vicinity of proton pumps, where [𝐻M] is higher than 10H[	𝑀, a higher concentration of catalase is 
required to protect the cancer cells from hydroxyl radical generation. It has been experimentally 
verified that in vitro the high concentration of proton pump derived protons controls the 
formation of peroxynitrous acid, which leads to the generation of hydroxyl radicals at the 
required site of a cancer cell 34. Lowering the pH could hence potentially have the same impact 
on the nitric oxide/peroxynitrite pathway as inactivating catalase. 
When the protonation of peroxynitrite has occurred, the equilibrium between peroxynitrite and 
peroxynitrous acid is described by [𝑂𝑁𝑂𝑂𝐻][𝑂𝑁𝑂𝑂H][𝐻M] = 𝐾hHF = 10 ⇔ [𝑂𝑁𝑂𝑂𝐻][𝑂𝑁𝑂𝑂H] = 10Hk. 
With 𝑝𝐾h = 6.8 and 𝑝𝐻 = 7, [𝑂𝑁𝑂𝑂𝐻][𝑂𝑁𝑂𝑂H] = 10H?.% ⇔ [𝑂𝑁𝑂𝑂𝐻] = [𝑂𝑁𝑂𝑂H] × 10H?.%, 
i.e., about 63% of the peroxynitrite has been protonated. 
For formation of hydroxyl radicals through reaction (8), the rate is 𝑑[•𝑂𝐻]𝑑𝑡 = 𝑘][𝑂𝑁𝑂𝑂𝐻] − 𝑘H][•𝑁𝑂%][•𝑂𝐻]. 
Since nitrogen dioxide and hydroxyl radicals will be formed in an equal amount and since [•𝑂𝐻] 
at time 𝑡 will be [•𝑂𝐻]~ = [•𝑁𝑂%]~ = [𝑂𝑁𝑂𝑂𝐻]? − [𝑂𝑁𝑂𝑂𝐻]~ ⇔ [𝑂𝑁𝑂𝑂𝐻]~ = [𝑂𝑁𝑂𝑂𝐻]? − [•𝑂𝐻]~, 
where [𝑂𝑁𝑂𝑂𝐻]? = [𝑂𝑁𝑂𝑂H]? × 10H?.%, 
the rate of hydroxyl radicals formation takes the form 𝑑[•𝑂𝐻]~𝑑𝑡 = 𝑘]([𝑂𝑁𝑂𝑂𝐻]? − [•𝑂𝐻]~) − 𝑘H]([•𝑂𝐻]~)%. 
Denoting [𝑂𝑁𝑂𝑂𝐻]? = 𝑥 and [•𝑂𝐻]~ = 𝑦 and considering the steady-state of [•𝑂𝐻]~, i.e. [•𝑂𝐻]~ =[•𝑂𝐻]::, 𝑘](𝑥 − 𝑦) − 𝑘H]𝑦% = 0 ⇔ 𝑦% + 𝑘]𝑦𝑘H] − 𝑘]𝑥𝑘H] = 0. 
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Expressing 𝑦 in terms of 𝑥 and only considering solutions where 𝑦 ≥ 0, yields 
𝑦 = − 𝑘]2𝑘H] + a 𝑘]2𝑘H]c% + 𝑘]𝑥𝑘H] . 
For	𝑥 = [𝐶𝐴𝑇]? = 0	𝑀, [𝑂𝑁𝑂𝑂H]?;? = [𝑂𝑁𝑂𝑂H]|h; = 10Hi	𝑀, i.e. 𝑥 = [𝑂𝑁𝑂𝑂𝐻]?;? = 10Hi.% 
and 𝑦 ∼ 2.5 ∗ 10HF?	𝑀. This is in excellent agreement with our numerical results (see previous 
section) and indicates that the subsequent reactions in the nitric oxide/peroxynitrite pathway can 
be divided into individual reactions where each of them are reaching equilibrium before the next 
reaction occurs when [𝐶𝐴𝑇]? = 0	𝑀. 
Now, what is the situation when [𝐶𝐴𝑇]? ≠ 0	𝑀? 
Having derived an analytical expression that relates [𝑂𝑁𝑂𝑂𝐻]?, and hence also [𝑂𝑁𝑂𝑂H]?, to [•𝑂𝐻]::, [𝑂𝑁𝑂𝑂𝐻]? as a function of  𝑥 = [𝐶𝐴𝑇]? has to be derived. Referring back to the 
discussion about the ratio (𝑟) between the rates of decomposition by catalase and formation of 
peroxynitrous acid, respectively, this can be achieved in terms of 𝑟. If we assume that these both 
reactions have formed product at time 𝑡 = 𝜏, where 𝑓[𝑂𝑁𝑂𝑂H]?;? has been consumed in the 
formation of [𝑂𝑁𝑂𝑂𝐻]?;? and (1 − 𝑓)[𝑂𝑁𝑂𝑂H]?;? has been consumed in the decomposition by 
catalase (0 ≤ 𝑓 ≤ 1 ), then 𝑟 = 𝑣U𝜏𝑣[𝜏 = 1 − 𝑓𝑓 , 
i.e., 𝑓 = 11 + 𝑟. 
Thus, for 𝑥 = [𝐶𝐴𝑇]? ≠ 0, [𝑂𝑁𝑂𝑂𝐻]?;? = 𝑓[𝑂𝑁𝑂𝑂H]?;? × 10H?.% = 11 + 𝑟 [𝑂𝑁𝑂𝑂H]?;? × 10H?.%. 
However, since there is an equilibrium between [𝑂𝑁𝑂𝑂H]~ and [𝑂𝑁𝑂𝑂𝐻]~, when peroxynitrite is 
decomposed by catalase, a fraction of the produced peroxynitrous acid will transform back to 
peroxynitrite to maintain the equilibrium. This is of course a continuous process that will start 
the moment that peroxynitrite starts to be decomposed by catalase, but let us assume that the 
process occurs in discrete cycles. In the first cycle, a fraction of the initially formed 
peroxynitrous acid will transform back to peroxynitrite: [𝑂𝑁𝑂𝑂H]F;? = [𝑂𝑁𝑂𝑂𝐻]?;? × 10?.%, 
where the subscript denotes that the species are formed in the first cycle. A fraction of the 
formed peroxynitrite will form peroxynitrous acid again. The concentration is [𝑂𝑁𝑂𝑂𝐻]F;? = 11 + 𝑟 [𝑂𝑁𝑂𝑂H]F;? × 10H?.% 
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= 11 + 𝑟 [𝑂𝑁𝑂𝑂𝐻]?;? = 1(1 + 𝑟)% [𝑂𝑁𝑂𝑂H]?;? × 10H?.%. 
 
In the same manner, the concentration of peroxynitrous acid in the 𝑖: 𝑡ℎ cycle will be given by [𝑂𝑁𝑂𝑂𝐻]';? = 1(1 + 𝑟)'MF [𝑂𝑁𝑂𝑂H]?;? × 10H?.%. 
If we replace	[𝑂𝑁𝑂𝑂𝐻]?;? in the derived analytical expression of [•𝑂𝐻]:: to [𝑂𝑁𝑂𝑂𝐻]';? and try 
for different values of 𝑖, this can give a clue to the behavior of the relation between 𝑥 = [𝐶𝐴𝑇]? ≠0 and 𝑦 = [•𝑂𝐻]:: . As it turns out, a similar relationship can be obtained if it is assumed that 𝑖 =𝑖(𝑟), i.e., 𝑖 is dependent of 𝑟. The dependence is such that 𝑖 is inversely dependent on 𝑟. It means 
that for a low catalase concentration, a higher number of cycles will be needed before hydroxyl 
radicals reaches a steady state. Since the rate of peroxynitrite decomposition is dependent on the 
concentration of peroxynitrite, it makes sense that the rate will be sufficiently high to affect the 
concentration of hydroxyl radicals for a higher number of cycles when a higher fraction of the 
peroxynitrite is used to form peroxynirous acid. For high catalase concentrations, i.e., 𝑟 is high, 
the major part of the available peroxynitrite will be depleted already in the first cycle. Hence, the 
concentration of peroxynitrite will be too low to create a significant rate of the catalase-
dependent decomposition of peroxynitrite and the hydroxyl radical concentration will reach a 
steady-state after a few cycles. 
The conclusion of this analysis is that it might be possible to qualitatively describe the overall 
behavior of the nitric oxide/peroxynitrite  pathway as a step-wise sequence of reactions. In 
particular, a cycle-dependent pseudo-steady-state concentration of peroxynitrous acid can be 
used to predict the qualitative behavior of the resulting steady-state concentration of hydroxyl 
radicals also when catalase is introduced in the reaction network. Even though an analytical 
solution of 𝑦(𝑥) probably does not exist due to the complex, nonlinear nature of the set of rate 
equations that govern the kinetics in the reaction network, the qualitative relationship: 
𝑦 = − 𝑘]2𝑘H] + a 𝑘]2𝑘H]c% + 𝑘][𝑂𝑁𝑂𝑂𝐻]';?𝑘H] , 
where 𝑖 = 𝑖(𝑟), might offer an interpretation of the key mechanisms underlying the resulting 
relationship between the concentration of catalase and the generation of hydroxyl radicals. 
 
 
5.4 Limitations of the model and potential implications 
 
In our mathematical model of the catalase-dependent kinetics of the reaction network of the 
hypochlorous acid- and the nitric oxide/peroxynitrite pathway, we only consider the closed system 
as it would appear in a well-mixed reaction vessel. More about the justification of this restriction 
can be found in section 3.1. The analysis of the kinetics of the reaction network itself has provided 
us with information about the maximal hydroxyl radical generation from the hypochlorous acid 
and nitric oxide/peroxynitrite pathways under the given conditions, and how the interaction with 
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catalase at various concentrations affects the resulting concentration of hydroxyl radicals. It has 
also revealed what concentrations of the involved ROS/RNS and enzymes are required for the 
hydroxyl radical generation from the hypochlorous acid- and nitric oxide/peroxynitrite pathways 
to represent a feasible mechanism underlying the selectivity of CAP for cancer treatment. 
However, in a more realistic, open system of the extracellular compartment, there are a number of 
effects that potentially could affect the results. These are in particular: 
 
• The spatial dynamics of the involved species.  
• The constant generation of some species (superoxide anions and nitric oxide in particular).  
• The effect of interfering pathways (which in general will cause a reduction of the 
generation of hydroxyl radicals, because the substrates of hydroxyl radicals generation are 
used in the formation of other products, e.g., in the formation of singlet oxygen	through 
interaction between hydrogen peroxide and peroxynitrite). 
 
First, the fact that our model does not predict a generation of hydroxyl radicals from the 
hypochlorous acid pathway, while experiments suggest that this should be the case, indicates that 
both in vitro and in vivo, the spatial dynamics might play an important role. If a fraction of 
superoxide anions diffuses away from its site of production before reacting with nitric oxide or 
SOD, it could serve as a reservoir of superoxide anions for hypochlorous acid to react with. 
However, the production of hydroxyl radicals from the hypochlorous acid pathway might then not 
occur in direct vicinity to the cell membrane, which reduces the chances for hydroxyl radicals to 
cause lipid peroxidation (and hence, apoptosis-induction). Furthermore, other studies in similar 
systems predict superoxide anions to be consumed within a very narrow spatial regime from its 
site of production 76-77 . Diffusion of nitric oxide from the site of production would lead to a 
decreased effective concentration close to the cell membrane, thus making it more likely for 
superoxide anions to enter the hypochlorous acid pathway. Still, the kinetics of this reaction 
network predicts that [•𝑁𝑂] has to decrease by many orders of magnitude and at the same time [𝑆𝑂𝐷]? must be very low, in order for (a very small amount of) hydroxyl radicals to be generated 
from the hypochlorous acid pathway. Furthermore, the total concentration of generated hydroxyl 
radicals from the reaction network will be reduced in such a case.  
 
Second, it can be discussed how the results would be expected to differ if a constant generation of 
the species superoxide anions and nitric oxide were included in the model. Considering the time 
scale (about 200 times longer than the time scale relevant here) to reach a steady-state 
concentration of nitric oxide  in a similar system 88, it can be assumed that adding such terms to 
the system of rate equations would not significantly change the results. If so, a constant generation 
of nitric oxide in the reaction network would obviously increase the fraction of superoxide anions 
entering the nitric oxide/peroxynitrite pathway. A constant generation of superoxide anions, on the 
other hand, should not change the qualitative result since also the newly generated superoxide 
anions would directly enter one of the two initial reactions in the reaction network - thus 
contributing to the formation of peroxynitrite and hydrogen peroxide - not to formation of hydroxyl 
radicals through reaction between hydrogen peroxide and superoxide anions. Thus, we believe the 
ratio of [•𝑂𝐻] to [𝑂%•H] would be unchanged. 
 
Third, including any of the interfering reactions would - with one exception - only lower the total 
production of hydroxyl radicals from the reaction network. The exception is that FASR (which is 
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an apoptosis-inducing membrane-receptor) can be triggered by singlet oxygen in the absence of 
its genuine ligand 106 - a process which activates caspase-8 and enhances the NOX1 activity as 
well as induces NOS expression 107-108. Thus, there will be an increased local generation of 
superoxide anions and nitric oxide. Referring back to the previous discussion, if this will 
significantly change the result, it will increase the peroxynitrite concentration, thus making the 
nitric oxide/peroxynitrite  pathway stronger. Including reactions where nitric oxide is consumed is 
also a possible way to decrease the effective concentration of nitric oxide, which would increase 
the amount of superoxide anions entering the hypochlorous acid pathway. Still, as already 
mentioned, this causes a lower total concentration of hydroxyl radicals generated from the total 
reaction network. 
 
In addition, we should also mention the effect of temperature and viscosity on the rate constants, 
especially since two important rate constants in the hypochlorous acid pathway (𝑘F and 𝑘G, see 
section 6.1) are from studies performed at room temperature (rather than at the relevant 
temperature of 37℃). However, it seems unlikely that these rate constants would be increased by 
many orders of magnitude due to the relatively small increase in temperature. Thus, we believe 
that the qualitative behavior of the reaction network would not change substantially by adjusting 
these rate constants to 37℃. The viscosity in the extracellular compartment is probably higher than 
the solutions for which the included rate constant values are determined for. Since this means a 
slower diffusion for the reacting species, it leads to less frequent collisions and thus lower rate 
constants. If this effect is more noticeable for some reactions than others, it could affect the results 
of the model. 
 
Regarding the nitric oxide/peroxynitrite pathway, we have not included the potential oxidation of 
nitric oxide by (active) catalase in this study. It has been excluded as the main effect of catalase 
on the nitric oxide/peroxynitrite pathway 34, but may be included in future models to rule out that 
it would have a significant effect on the concentration of nitric oxide. Two other aspects would be 
more important to include in the study of this pathway though. First, in biological systems the 
reaction between peroxynitrite and carbon dioxide 109-112 is considered to be the major route of 
peroxynitrite decomposition since the physiological concentration of carbon dioxide is high ((1 −3) × 10H%	𝑀) 113. To achieve a more realistic result of the true concentration of the generated 
hydroxyl radicals, this reaction is hence crucial to include. Second, studies show that the formation 
of hydroxyl radicals from peroxynitrous acid should rather be written as 𝑂𝑁𝑂𝑂𝐻 → 𝑓 a•𝑂𝐻+•𝑁𝑂%c + (1 − 𝑓)(𝐻M + 𝑁𝑂IH), 
where 0 ≤ 𝑓 ≤ 1 is the fraction of peroxynitrous acid that undergoes radical escape. The yield of 
hydroxyl radicals from decomposition of peroxynitrous acid, according to the literature, varies 
within the range 0 − 40% 114-120, i.e. 𝑓 ≤ 0.4	whereas in this study, 𝑓 = 1, was assumed. 
 
Regarding the hypochlorous acid pathway and the discrepancy between our results (which predict 
that hydroxyl radicals is not generated from this pathway) and the experimental findings, an aspect 
that should be brought up in the discussion about this pathway, is that it has been shown that 
superoxide anions can be generated by two common components of cell culture media: HEPES 
buffer and (in the presence of light) riboflavin 121 . Thus, for in vitro studies in such cell culture 
media, some of the superoxide anions production might be attributed to the generation of the media 
and not by the cells themselves. In e.g. refs. 68, 70, where the hypochlorous acid pathway was 
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studied, Eagle’s Minimal Essential Medium was used for the cell cultures. Since Eagle’s Minimal 
Essential Medium contains riboflavin and since there is nothing mentioned about the light 
conditions for these experiments, it cannot be ruled out that the results from these studies are 
affected by the production of superoxide anions by the culture medium. Another aspect regarding 
this pathway is that possible SOD-inactivation of CAP indicates that the hypochlorous acid 
pathway might be less important than the nitric oxide/peroxynitrite pathway in the context of 
apoptosis-induction by CAP. Indeed, since SOD shares the common feature of histidine at the 
active site with catalase, it is reasonable to assume that also SOD is inactivated by CAP in the 
same manner as catalase. It has been shown that the histidine residue of SOD is inactivated by 
singlet oxygen even more effectively than the histidine residue of catalase 122-123. In such a case, 
the probability of SOD inactivation by CAP should be even higher than catalase inactivation. The 
immediate effect of SOD inactivation is that the rate of hydrogen peroxide formation is decreased 
whereas the peroxynitrite concentration is increased. Furthermore, the increased concentration of 
superoxide anions may cause catalase inhibition. In ref. 105 it is verified that inhibition of SOD 
increases the concentration of superoxide anions, which inhibits catalase and removes the 
enzymatic dismutation of superoxide anions to hydrogen peroxide, thus inhibiting the 
hypochlorous acid pathway. It has indeed been shown that inactivation of SOD indirectly inhibits 
catalase through superoxide anions dependent inhibition 124. In this study, inactivation of SOD was 
also found to cause a drastic decrease of hydrogen peroxide. 
 
In ref. 125 another potential effect, contributing to hydroxyl radical induced apoptosis, is mentioned. 
In the case of aquaporins in the vicinity of inactivated catalase, hydrogen peroxide could be 
transferred from the extracellular compartment to the intracellular compartment. Here, hydrogen 
peroxide would cause depletion of glutathione - a process that makes the cell more sensitive to 
extracellular hydroxyl radicals. The resulting effect might be that the more catalase that is 
inactivated, the less amount of hydroxyl radicals is required to induce apoptosis. In such a case, 
catalase does not have to be inactivated to such a high extent that our results suggest, i.e., our 
results might have to be adjusted. This hypothesis is of course based on the assumption that there 
is a sufficient amount of hydrogen peroxide in the extracellular compartment, i.e., SOD must not 
have been inactivated to a large extent by singlet oxygen. 
 
Lastly, there are some additional effects, not included in the model, that also could change the 
results. These are: 
 
• The difference in catalytic action of membrane-bound enzymes as compared to enzymes 
that are free in solution. 
• The effect of non-equilibrium on the rate constants. 
• The potential enzyme inhibition by the products (or other species). 
• The pH-dependence of enzyme activity. 
 
These effects are, however, all very difficult to take into account, but may play an important role 
in in vivo systems.  In summary, our model merely serves as a first step in the theoretical 
investigation of the catalase-dependence of the apoptosis-inducing signaling pathways suggested 
in ref. 37. Further improvement will be needed, but the model already gives important insights 
about necessary conditions in terms of concentrations of enzymes and ROS/RNS in order for both 
the hypochlorous acid- and nitric oxide/peroxynitrite pathway to be inhibited and reactivated.  
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6. Conclusions 
 
In this work, we have developed and used a mathematical model to analyze and gain insights about 
a specific mechanism, which has been described in great detail and is proposed to explain 
selectivity of CAP for cancer treatment 37. Explicitly, the model describes the catalase-dependent 
reaction kinetics of two apoptosis-inducing signaling pathways occurring in the extracellular 
compartment of cancer cells. By implementing this model, we investigated the possibility to 
reactivate the generation of hydroxyl radicals (responsible for inducing apoptosis) from the 
reaction network of both pathways by inactivation of catalase (which is proposed to occur upon 
CAP treatment). Our analysis reveals that only one of these pathways seems feasible in the context 
of hydroxyl radicals generation under relevant conditions, and this pathway requires very high 
catalase concentrations - about 1	𝑚𝑀 - to be inhibited. In the absence of other interfering pathways 
and for [𝑆𝑂𝐷]? ≲ 10H[	𝑀, this can indeed be assumed to be the condition of the extracellular 
compartment of cancer cells before CAP treatment (given that the mechanism in ref. 37 is valid). 
In order to reactivate this pathway, about 99% of the catalase has to be inactivated. 
 
The fact that our model fails to reproduce the reactivation of the second pathway, might indicate 
that further developments are needed to capture the complexity of the signaling pathways in their 
in vitro and in vivo context. Especially, diffusion may be of importance to decrease the effective 
concentration of some species close to the cell membrane. Still, the kinetics of this pathway is very 
unfavorable and it might also be relevant to investigate other possible mechanisms for hydroxyl 
radical generation from this pathway. 
 
In spite of the limitations of the model, we believe this work contributes to a better understanding 
of one of the mechanisms possibly underlying the selectivity of CAP for cancer treatment. 
Especially, it provides insights into the necessary conditions for the mechanism to operate the way 
proposed and indicates that other possible mechanisms underlying the selectivity of CAP should 
be considered and analyzed as well. 
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Appendix 
 
We present here more detailed information about the rate equations and rate constants used, as 
well as how the effective radius of enzyme molecules was found. 
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A1. Rate equations and rate constants 
 
A1.1. General information 
 
Reaction (3) and (5) follow Michaelis-Menten kinetics, i.e., 
 𝑑[𝑃]𝑑𝑡 = 𝑘[𝐸]? [𝑆]𝐾 + [𝑆], 𝑑[𝑆]𝑑𝑡 = −𝑑[𝑃]𝑑𝑡 , 𝑑[𝐸]𝑑𝑡 = 0, 
 
where [𝑆] denotes the substrate concentration, [𝑃] denotes the product concentration, [𝐸]? denotes 
the initial enzyme concentration, 𝑘 is the catalytic constant for enzyme 𝐸 and 𝐾 is the Michaelis-
Menten constant for enzyme 𝐸. For a reaction of the type  
 𝑛𝑆 + 𝐸 → 𝐸 +𝑚𝑃, 
 
we assume the rate equation  
 −1𝑛 𝑑[𝑆]𝑑𝑡 = 1𝑚𝑑[𝑃]𝑑𝑡 , 
 
to be valid. 
 
A1.2. Reaction (1) 
 
In ref. 126 we found that the activity of (bovine) SOD is relatively independent of 𝑝𝐻 between 5.3 
and 9.5. In ref. 97 we found that bovine SOD is catalyzing the decay of superoxide anions with a 
second order rate constant, 𝑘F = 2.3 × 10i	𝑀HF𝑠HF, at 𝑇 = 20 − 25℃ and 𝑝𝐻 = 7.0, where the rate 
of superoxide anions decay is given as 
 𝑑[𝑂%•H]𝑑𝑡 = −𝑘F[𝑂%•H][𝑆𝑂𝐷]. 
 
The rate of formation of hydrogen peroxide should hence follow 
 𝑑[𝐻%𝑂%]𝑑𝑡 = 12𝑘F[𝑂%•H][𝑆𝑂𝐷]. 
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In ref. 95, we found that for (bovine) SOD at 𝑇~25℃ and 𝑝𝐻 between 9.0 and 9.9, the second-order 
rate constant for superoxide anions decay is 𝑘F = 2.4 × 10i	𝑀HF𝑠HF. The average of both values 
for 𝑘F is used in our calculations, i.e., 𝑘F = 2.35 × 10i	𝑀HF𝑠HF. 
 
A1.3. Reaction (2) 
 
In ref. 127 the second order rate constant for the decay of superoxide anions at 𝑇 = 20 − 25℃ and 𝑝𝐻 = 7.5 was determined to be 𝑘% = (6.7 ± 0.9) × 10i	𝑀HF𝑠HF. The rate of the decay of superoxide 
anions hence is 
 𝑑[𝑂%•H]𝑑𝑡 = 𝑑[•𝑁𝑂]𝑑𝑡 = −𝑘%[𝑂%•H][•𝑁𝑂], ⇒ 𝑑[𝑂𝑁𝑂𝑂H]𝑑𝑡 = 𝑘%[𝑂%•H][•𝑁𝑂]. 
 
In ref. 128 the rate constant for superoxide anions decay was shown to be independent of 𝑝𝐻 in the 
range 6.1 − 10.0 and the rate constant was determined to be 𝑘% = (4.3 ± 0.5) × 10i	𝑀HF𝑠HF (no 
information on 𝑇).  In ref. 100, the rate constant was found to be 𝑘% = 4.8 × 10i	𝑀HF𝑠HF at 𝑇 = 25℃  
and in ref. 129 the weighted average of three different experiments gave a value of 𝑘% =(1.6 ± 0.3) × 10F?	𝑀HF𝑠HF (no information on 𝑇). In ref. 93, a value of 𝑘% = 3.2 × 10F?	𝑀HF𝑠HF at 𝑇 = 25℃ was reported. In ref. 93 it was furthermore concluded that the expected rate constant at 𝑇 = 37℃ is 𝑘% = 1.7 × 10F?	𝑀HF𝑠HF. We used the latter value in our calculations since it is the only 
value found for the right temperature condition (𝑇 = 37℃). 
 
The value of the first order rate constant for the reverse reaction is 𝑘H% = 0.017	𝑠HF in aqueous 
solutions at 𝑇 = 20℃ 101 as well as at  𝑇 = 25℃ 100, i.e., 
 𝑑[𝑂𝑁𝑂𝑂H]𝑑𝑡 = −𝑘H%[𝑂𝑁𝑂𝑂H] 
 ⇒ 𝑑[𝑂%•H]𝑑𝑡 = 𝑑[•𝑁𝑂]𝑑𝑡 = 𝑘H%[𝑂𝑁𝑂𝑂H]. 
 
 
A1.4. Reaction (3) 
 
The reaction follows Michaelis-Menten kinetics (at [𝐻%𝑂%] ≤ 200	𝑚𝑀). Apparent values of 𝐾I and 𝑘I at 𝑝𝐻 = 7.0 and 𝑇 = 37℃ are 𝐾I = 80.0	𝑚𝑀 and 𝑘I = 587000.0	𝑠HF 91 . Note that in this reaction, 
it is assumed that the product is oxygen. 
 
 
A1.5. Reaction (4) 
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The reaction was found to be catalyzed by bovine liver catalase with a (second order) rate constant, 𝑘U = 1.7 × 10G	𝑀HF𝑠HF at 𝑝𝐻 = 7.1 and 𝑇 = 25℃ 72. The rate of the decay of peroxynitrite can 
hence be expressed as  
 𝑑[𝑂𝑁𝑂𝑂H]𝑑𝑡 = −𝑘U[𝑂𝑁𝑂𝑂H][𝐶𝐴𝑇]. 
 
At 𝑇 = 37℃, the rate constant of peroxynitrite decay was found to be 2.5 − 3 times higher than that 
measured at 𝑇 = 25℃. However, the authors noted that this result can only serve as an estimation 
due to some experimental errors. Since the difference in value anyway does not differ by many 
orders of magnitude, we choose to use the experimental value for 𝑇 = 25℃ in our calculations. 
 
 
A1.6. Reaction (5) 
 
The reaction follows Michaelis-Menten kinetics (with 𝐻%𝑂% as the substrate). The effect of [𝐶𝑙H] 
and 𝑝𝐻 (4.4 ≤ 𝑝𝐻 ≤ 6.2) on the 𝐾W-value at 𝑇 = 37℃  for hydrogen peroxide of MPO has been 
studied 130 and it shows that the 𝐾W-values decreases with increasing [𝐶𝑙H] and 𝑝𝐻 in a dose-
dependent manner. In other words, as 𝑝𝐻 increases, 𝐾W becomes less sensitive to the concentration 
of chlorine anions. Hence, for 𝑝𝐻~7, it should be a valid assumption that 𝐾W changes only very 
little with changing [𝐶𝑙H]. For MPO from leukocytes at 𝑝𝐻 = 7.2, 𝑇 = 20℃, [𝐻%𝑂%] = 100	𝜇𝑀 and [𝐶𝑙H] = 200	𝑚𝑀, 𝑘W = 320	𝑠HF per monomer (MPO is a homodimer, i.e., it consists of two 
monomers, so the effective concentration of MPO is twice the given one) and 𝐾W = 30	𝜇𝑀 during 
the first 100	𝑚𝑠 92 with respect to 𝐻%𝑂%. Thereafter, 𝑘W decreases. For lower concentrations of  
hydrogen peroxide ([𝐻%𝑂%] < 50	𝜇𝑀), 𝑘W is less dependent on time. Thus, for the current 
calculations ([𝐻%𝑂%] ≪ 50	𝜇𝑀) it can be justified to assume that 𝐾W = 30	𝜇𝑀 is a constant in time. 
 
 
A1.7. Reaction (6) 
 
At 𝑝𝐻 = 5.5 and 𝑇~20℃, the decay of 𝑂%•H in the presence of hypochlorous acid has been 
determined to occur with a second order rate constant 𝑘G = 7.5 × 10G	𝑀HF𝑠HF 94 , i.e., 
 𝑑[𝑂%•H]𝑑𝑡 = −𝑘G[𝑂%•H][𝐻𝑂𝐶𝑙], ⇒ 𝑑[•𝑂𝐻]𝑑𝑡 = 𝑘G[𝑂%•H][𝐻𝑂𝐶𝑙]. 
 
Since no reported value of 𝑘HG could be found and hydroxyl radicals is known to be a very reactive 
species, thus reacting with almost any other species in its surrounding, we assume that the reverse 
reaction is of minor importance and 𝑘HG is set to 0. (A value 𝑘HG > 0 will only reduce [•𝑂𝐻]). 
 
 
 
 
30 
 
A1.8. Reaction (7) 
 
The ratio of 𝑘[ and 𝑘H[ is given by 
 𝐾h = [𝑂𝑁𝑂𝑂H][𝐻M][𝑂𝑁𝑂𝑂𝐻] = 𝑘H[𝑘[ = 10H	𝑀HF. 
 
The 𝑝𝐾h-value at 𝑇 = 25℃ is 6.5 − 6.8 102, 131. To optimize the production of hydroxyl radicals, we 
chose 𝑝𝐾h = 6.8 in our calculations. 
 
Diffusion-controlled second-order rate constants of protonation of a wide range of compounds are 
within (0.35 − 18) × 10F?	𝑀HF𝑠HF 96. We chose 𝑘[ = 10F?	𝑀HF𝑠HF in our calculations.	
 
 
A1.9. Reaction (8) 
 
The rate constants in reaction (8) are 𝑘] = 10HU − 0.6	𝑠HF at 𝑇 = 25℃ 98 and 𝑘H] =(4.5 ± 1.0) × 10i	𝑀HF𝑠HF (𝑝𝐻 = 9.5 and no information about 𝑇) 99, i.e., 
 𝑑[𝑂𝑁𝑂𝑂𝐻]𝑑𝑡	 = 𝑘H][•𝑁𝑂%][•𝑂𝐻] − 𝑘][𝑂𝑁𝑂𝑂𝐻], 
and 
 𝑑[•𝑂𝐻]𝑑𝑡 = −𝑘H][•𝑁𝑂%][•𝑂𝐻] + 𝑘][𝑂𝑁𝑂𝑂𝐻]. 
 
To find the upper limit of the hydroxyl radicals production from the nitric oxide/peroxynitrite 
pathway, we use the largest possible value for 𝑘], i.e., 𝑘] = 0.6	𝑠HF, and the smallest possible value 
for 𝑘H], i.e., 𝑘H] = 3.5 × 10i	𝑀HF𝑠HF. 
 
 
A2. Enzyme effective radius 
 
The effective radius of the enzymes are found by the following procedure: The pdb-file for each 
respective enzyme is downloaded on the protein data bank www.rcsb.org. This file is then 
uploaded into the protein volume calculating program “Voss Volume Voxelator” 
(http://3vee.molmovdb.org/index.php), which calculates the effective radius of the enzyme. 
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A2.1. Catalase 
 
The crystal structure of catalase (homo sapiens) was taken from ref. 132. The calculations yield the 
effective radius equal to 25.10 Å. This yields a maximum concentration of 13.1	𝑚𝑀. 
 
A2.2. SOD 
 
The crystal structure of SOD (homo sapiens) was taken from ref. 133. The calculations yield an 
effective radius of 15.70 Å. This yields a maximum concentration of 53.6	𝑚𝑀. 
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